Walid Shalata

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors

Walid Shalata, Sarah Weissmann, Sapir Itzhaki Gabay et al. · Cancers · 2022 · 31 citations · Full text

Immunodeficiencies, Immunology, Immunoediting +17

Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety

Walid Shalata, Itamar Gothelf, Tomer Bernstine et al. · Cancers · 2024 · 29 citations · Full text

Psychotherapy, Psychological Co-morbidities, Cancer Management +19

Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study

Nir Peled, Laila C. Roisman, Esther Levison et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 22 citations

Surgical Oncology, Neoadjuvant Osimertinib Followed, Medicine +9

Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience

Walid Shalata, Jeremy Zolnoorian, Gabrielle Migliozzi et al. · International Journal of Molecular Sciences · 2023 · 21 citations · Full text

Real-world Experience, Medicine, Immune Checkpoint Inhibitors +14

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry

Giannis Mountzios, David Planchard, Giulio Metro et al. · JTO Clinical and Research Reports · 2022 · 18 citations · Full text